C07D 295/033
With the ring nitrogen atoms directly attached to carbocyclic rings
Official title: with the ring nitrogen atoms directly attached to carbocyclic rings
C07D295/033 (With the ring nitrogen atoms directly attached to carbocyclic rings) appears on 152 US grants and 150 published applications in this corpus.
Search patents in C07D- Granted patents
- 152
- Published applications
- 150
- Assignees
- 114
- Inventors
- 516
- Latest grant
- 2 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 8 | 0 |
| 1977 | 2 | 0 |
| 1978 | 4 | 0 |
| 1979 | 0 | 0 |
| 1980 | 3 | 0 |
| 1981 | 2 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 4 | 0 |
| 1985 | 1 | 0 |
| 1986 | 2 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 4 | 0 |
| 1991 | 3 | 0 |
| 1992 | 5 | 0 |
| 1993 | 4 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 2 | 1 |
| 2002 | 3 | 4 |
| 2003 | 2 | 5 |
| 2004 | 2 | 5 |
| 2005 | 5 | 12 |
| 2006 | 5 | 8 |
| 2007 | 4 | 5 |
| 2008 | 1 | 4 |
| 2009 | 3 | 5 |
| 2010 | 3 | 7 |
| 2011 | 3 | 8 |
| 2012 | 4 | 6 |
| 2013 | 4 | 4 |
| 2014 | 10 | 8 |
| 2015 | 6 | 7 |
| 2016 | 5 | 9 |
| 2017 | 9 | 6 |
| 2018 | 2 | 3 |
| 2019 | 3 | 7 |
| 2020 | 6 | 7 |
| 2021 | 0 | 6 |
| 2022 | 5 | 5 |
| 2023 | 3 | 4 |
| 2024 | 1 | 5 |
| 2025 | 7 | 7 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compounds advantageous in the treatment of central nervous system diseases and disorders2 Dec 2025US 12,486,218 B2Aurimmed Pharma, Inc.
- Chalcone-based chemotherapeutic compound for triple negative breast cancer30 Sep 2025US 12,428,405 B2Qatar University
- Organic electroluminescent materials and devices5 Aug 2025US 12,378,197 B2Universal Display Corporation
- Urea compound for antagonizing LPA1 receptor24 Jun 2025US 12,338,203 B2Taisho Pharmaceutical Co., Ltd.
- Compounds useful for treating gastrointestinal tract disorders22 Apr 2025US 12,281,103 B2Ardelyx, Inc.
- Chalcone-based chemotherapeutic compounds and treatments for cancer23 Jul 2026US 2026/0209209 A1Qatar University
- Masp-2 inhibitors and methods of use9 Jul 2026US 2026/0193179 A9Omeros Corporation
- Masp-2 inhibitors and methods of use11 Dec 2025US 2025/0376443 A1Omeros Corporation
- Masp-2 inhibitors and methods of use4 Dec 2025US 2025/0368604 A1Omeros Corporation
- Method for producing aryl compound containing tritylsulfanyl group13 Nov 2025US 2025/0346557 A1AGC Inc.
Most cited
By later US patents
- Photoreactive lenses with adamantane spiro compounds159US 4,818,096 APlessey Incorporated · 1989
- Sigma receptor ligands and the use thereof150US 6,057,371 AVirginia Commonwealth University · 2000
- Ligands for metals and improved metal-catalyzed processes based thereon143US 6,307,087 B1Massachusetts Institute of Technology · 2001
- Hydrogenated naphthalenes137US 4,391,731 AHoffmann-La Roche Inc. · 1983
- Ligands for metals and improved metal-catalyzed processes based thereon100US 6,395,916 B1Massachusetts Institute of Technology · 2002